A microRNA that regulates inflammation shows promise as a treatment for inflammatory diseases such as asthma and cancer, according to research published in Cell Reports.
The microRNA, known as miR-223, is highly expressed in blood cells that cause inflammation (neutrophils). When they’re working correctly, those blood cells help protect the human body against infections, but sometimes they damage host tissue instead of microbes, causing chronic inflammation and disease.
To uncover the link between miR-223 and inflammation, a Purdue University research team created a zebrafish totally deficient of miR-223. Then they cut off a small chunk of its fin.
“The inflammation was really robust,” said Qing Deng, a professor of biological sciences at Purdue and corresponding author of the paper. “Neutrophils accumulated at the wound and they just kept coming. This is consistent with the literature, but we wanted to understand why.”
Extensive gene expression analysis led them to pathway NF-kB, a protein complex found in nearly all animal cell types that regulates inflammation and cell proliferation. Heightened activation of this pathway is the cause of increased inflammation, although it’s limited to the deeper, or basal, layer of the epithelium. This means any therapeutics would need to reach the basal layer to work.
The same pathway plays an important role in human bronchial epithelial cells, which are critical in the development of asthma, according to the study. MiR-223 suppresses the pathway, which means supplementing it to epithelial cells could help control inflammatory disease.
“We don’t have human trials yet, but we think it’s promising,” Deng said. “Instead of using steroids to drive away the immune cells, maybe this microRNA could be given.”
Learn more: MicroRNA could help treat cancer and asthma
The Latest on: MicroRNA
- Using nanocarrier-delivered microRNA to target sepsis on December 3, 2018 at 9:44 am
One in three patients who die in the U.S. dies of sepsis, according to the Centers for Disease Control and Prevention. It is one of the leading causes of death in intensive care units and, with an est... […]
- Targeting sepsis, the leading cause of ICU deaths, with a nanocarrier-delivered microRNA on December 3, 2018 at 9:30 am
Dr. Fan is senior author on the Inflammation article and an assistant professor in the Department of Pathology and Laboratory Medicine at MUSC who studies vascular dysfunction in sepsis. […]
- Blocker targeting microRNA-181a-5p successfully treats knee, spine OA on December 3, 2018 at 2:41 am
A blocker consisting of locked nucleic acid antisense oligonucleotides, targeting the biomarker microRNA-181a-5p, is successful in protecting cartilage in spine and knee osteoarthritis, according to d... […]
- MicroRNA Profilers Cite Reconcilable Differences on November 30, 2018 at 11:03 am
According to a recent study led by the University of Michigan’s Muneesh Tewari, M.D., Ph.D., RNA-sequencing library preparation methods may inconsistently quantitate microRNAs. The study, which evalua... […]
- SUO 2018: Development of Serum MicroRNA as a Novel and Better Tumor Marker for Testicular Germ Cell Tumor than HCG and AFP on November 30, 2018 at 10:07 am
Phoenix, Arizona (UroToday.com) In this first talk by Dr. Kollmannsberger, the focus is on serum micro-RNA’s (miRNA) as a novel and potentially superior tumor marker for testicular germ cell tumors (G... […]
- Light cast on the role of microRNA on animal domestication on November 24, 2018 at 1:01 pm
A molecular study into key domesticated animals, including the horse, has highlighted the role of microRNAs in our selective guidance of these species into the many breeds we see today. If DNA is an o... […]
- Systemic control of legume susceptibility to rhizobial infection by a mobile microRNA on November 13, 2018 at 7:38 am
1 Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark. 2 Zentrum für Molekularbiologie der Pflanzen, Tübingen University, Tübingen, Germany. ↵#Corresponding author. Email: ... […]
- Tracking down microRNA candidates that can contribute to disease on November 7, 2018 at 7:01 am
What started as Ninad Oak’s side project turned out into something much larger, his doctorate thesis. “The project started as my qualifying exam that I proposed at the end of my first year of graduate ... […]
- Tracking down microRNA candidates that can contribute to disease on November 6, 2018 at 9:02 am
"The project started as my qualifying exam that I proposed at the end of my first year of graduate school," said Oak, a graduate student in molecular and human genetics in Dr. Sharon E. Plon's lab. "T... […]
- Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques on October 31, 2018 at 11:07 am
1 Horae Gene Therapy Center, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, USA. 2 Shire, 125 Binney Street, Cambridge, MA 02142, USA. 3 Department of Neurolog... […]
via Google News and Bing News